Rough draft #1
The One 24
Roughdraftapprasial.docxRead article attahed to link then answer question on the appraisal recommendations. All yes/no question need a 1-3 sentence explanation.
https://www.acpjournals.org/doi/10.7326/M14-0198?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&
Completed Appraisal of Recommendations of Clinical Practice Guideline
Citation:
Synopsis
What does the guideline address? Clinical questions, conditions, interventions?
What population of patients does the guideline address?
Did the panel use existing SRs or did they conduct their own?
What clinical outcomes was the guideline designed to achieve?
What are the main recommendations?
What is the date on it and how recent are the cited evidence sources?
What system was used to grade the recommendations?
Credibility
Was the panel made up of people with the necessary expertise?
□Yes □ No □ Not clear
Are the goals for developing the guideline explicit and clear?
□ Yes □ No □ Not clear
* Does the guideline production process include all the widely recognized steps?
□ Yes □ No □ Not clear
*Were the SRs used of high quality?
□ Yes □ No □ Not clear
Are differences in evidence for sub-populations recognized?
□ Yes □ No □ Not clear
*Is the evidence supporting each recommendation graded or stated as adequate to strong?
□ Yes □No □ Not clear
Is the guideline current? (based on issue date and date of most recent evidence included)
□ Yes
Is the panels’ confidence in each recommendation clear?
□ Yes □ No □ Not clear
ARE thE RECommENDAtIoNS CREDIblE?
□ Yes □ No □Some
Clinical Significance
Are essential elements of any recommended action or intervention clearly stated?
□ Yes □ No □ Not clear
*Is the magnitude of benefit associated with each recommendation clinically important?
□ Yes □ No □ Not clear
*Is the panel’s certainty or confidence in each recommendation clear?
□ Yes □ No □ Not clear
Were patient concerns, values, and risks addressed?
□ Yes □ No □ Not clear
Were downsides or costs of each recommendation addressed?
□ Yes □ No □ Not clear
Was the guideline reviewed by outside experts and a member of the public or field tested?
□ Yes □ No □ Not clear
ARE thE RECommENDAtIoNS ClINICAlly SIGNIfICANt?
□ Yes All □ Yes Some □ No
Applicability
Does the guideline address a problem, weakness, or decision we are examining in our setting?
□ Yes □ No
Did the research evidence involve patients similar to ours and was the setting similar to ours?
□ Yes □ No □ Some
What changes, additions, training, or purchases would be needed to implement and sustain a clinical protocol based on these conclusions? Specify.
*Is what we will have to do to implement the new protocol realistically achievable by us (resources, capability, commitment)?
□ Yes □ No □ Not clear
Which departments and/or providers will be affected by a change? Specify.
*How will we know whether our patients are benefiting from our new protocol?
Are these recommendations applicable to our setting?
□ Yes □ No □ Some
ShoulD wE PROCEED to design a protocol based on these recommendations?
□ Implement all □ Implement some □ No
